Skip to main content

Turning Point Therapeutics, Inc.

TPTXDelisted Aug 17, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001595893

Turning Point Therapeutics, Inc. was delisted on Aug 17, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 209 institutions reported holding it in 13F filings for Q2 2022, worth $3.29B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q4 2021

Institutional positions in Turning Point Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
172
−17 vs. Q3 2021
Shares held
45.1M
+238.9K (+0.5%) vs. Q3 2021
Total value
$2.15B
−$837.0M (−28.0%) vs. Q3 2021
New holders
25
75 more added
Sold out
42
55 more reduced

2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TPTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 172 institutions
Q1 2021: 202 institutionsQ2 2021: 190 institutionsQ3 2021: 191 institutionsQ4 2021: 172 institutionsQ1 2022: 154 institutionsQ2 2022: 209 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2021: $2.15B
Q1 2021: $4.21BQ2 2021: $3.59BQ3 2021: $2.98BQ4 2021: $2.15BQ1 2022: $1.23BQ2 2022: $3.29BQ3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding TPTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 2022209$3.29B
Q1 2022154$1.23B
Q4 2021172$2.15B
Q3 2021191$2.98B
Q2 2021190$3.59B
Q1 2021202$4.21B

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Turning Point Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding TPTX in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Squarepoint Ops LLC0$00.00%−3,155−100.0%Sold out
Aigen Investment Management, LP0$00.00%−3,109−100.0%Sold out
Quantbot Technologies LP0$00.00%−1,372−100.0%Sold out
Penserra Capital Management LLC0$00.00%−1,125−100.0%Sold out
Acadian Asset Management LLC0$00.00%−520−100.0%Sold out
Meeder Asset Management Inc0$00.00%−353−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−288−100.0%Sold out
Ellevest, Inc.0$00.00%−132−100.0%Sold out
Spire Wealth Management0$00.00%−100−100.0%Sold out
Agf Investments Inc.0$00.00%−88−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−54−100.0%Sold out
Concord Wealth Partners0$00.00%−28−100.0%Sold out
Carroll Financial Associates, Inc.0$00.00%−6−100.0%Sold out
Meridian Wealth Partners, LLC0$00.00%−2−100.0%Sold out
First Mercantile Trust Co––––Not filed
Berman Capital Advisors, LLC––––Not filed